Non–Small Cell Lung Cancer: Prospective Comparison of Integrated FDG PET/CT and CT Alone for Preoperative Staging

PURPOSE: To evaluate prospectively the accuracy of integrated positron emission tomography (PET) and computed tomography (CT) with use of fluorodeoxyglucose (FDG), compared with that of stand-alone CT, for the preoperative staging of non–small cell lung cancer, with surgical and histologic findings used as the reference standard.

MATERIALS AND METHODS: Institutional review board approval and patient informed consent were obtained. From November 2003 to February 2004, 106 patients (78 men, 28 women; mean age, 56 years) with non–small cell lung cancer underwent curative surgical resection (tumor resection and lymph node dissection) after stand-alone CT followed by integrated FDG PET/CT. Tumor stages were determined by using the TNM and American Joint Committee on Cancer staging systems. Histopathologic results served as the reference standard. Statistically significant differences in tumor staging between integrated PET/CT and stand-alone CT were determined with P < .05 obtained by using the McNemar test or with a generalized estimating equation.

RESULTS: The primary tumor was correctly staged in 84 patients (79%) at stand-alone CT and in 91 patients (86%) at integrated FDG PET/CT (P = .25). For the depiction of malignant nodes, the sensitivity, specificity, and accuracy of CT were 70% (23 of 33 nodal groups), 69% (248 of 360), and 69% (271 of 393), respectively, whereas those of PET/CT were 85% (28 of 33), 84% (302 of 360), and 84% (330 of 393) (P = .25, P < .001, and P < .001, respectively). There were 112 false-positive interpretations at CT for 54 hilar, 16 subcarinal, 29 paratracheal, 10 subaortic, and two pulmonary ligament nodal groups and one upper paratracheal group, compared with only 58 false-positive interpretations at PET/CT for 32 hilar, seven subcarinal, 13 lower paratracheal, and six subaortic nodal groups. There were 10 false-negative interpretations at CT for four hilar, two lower paratracheal, and two subcarinal nodal groups, one prevascular and retrotracheal group, and one inferior pulmonary group, but only five false-negative interpretations at PET/CT (one each for paratracheal, subaortic, subcarinal, inferior pulmonary, and hilar nodal groups).

CONCLUSION: Integrated FDG PET/CT is significantly better than stand-alone CT for lung cancer staging and provides enhanced accuracy and specificity in nodal staging.

© RSNA, 2005


  • 1 Tanaka F, Yanagihara K, Otake Y, et al. Surgery for non-small cell lung cancer: postoperative survival based on the revised tumor-node-metastasis classification and its time trend. Eur J Cardiothorac Surg 2000; 18: 147–155. Crossref, MedlineGoogle Scholar
  • 2 McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319–323. LinkGoogle Scholar
  • 3 Beyer T, Townsend DW, Blodgett TM. Dual-modality PET/CT tomography for clinical oncology. Q J Nucl Med 2002;46:24–34. MedlineGoogle Scholar
  • 4 Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996;111:642–648. Crossref, MedlineGoogle Scholar
  • 5 Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521–527. Crossref, MedlineGoogle Scholar
  • 6 Yoon YC, Lee KS, Shim YM, Kim BT, Kim K, Kim TS. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection—prospective study. Radiology 2003;227:764–770. LinkGoogle Scholar
  • 7 Konishi J, Yamazaki K, Tsukamoto E, et al. Mediastinal lymph node staging in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration 2003;70:500–506. Crossref, MedlineGoogle Scholar
  • 8 Choi JY, Lee EJ, Kim YH, et al. Significance of hilar node uptake on FDG PET in patients with esophageal cancer (abstr). J Nucl Med 2003;44:21P–22P. Google Scholar
  • 9 Magnani P, Carretta A, Rizzo G, et al. FDG/PET and spiral CT image fusion for mediastinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg (Torino) 1999;40:741–748. MedlineGoogle Scholar
  • 10 Goerres GW, Kamel E, Seifert B, et al. Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med 2002;43:1469–1475. MedlineGoogle Scholar
  • 11 Yoon SB, Kim BT, Choi JY, et al. Role of PET in evaluating indeterminate solitary pulmonary nodule with CT. Korean J Nucl Med 1997;31:83–89. [Korean] Google Scholar
  • 12 AJCC cancer staging manual. 6th ed. New York, NY: Springer, 2002; 165–177. Google Scholar
  • 13 Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718–1723. Crossref, MedlineGoogle Scholar
  • 14 Glazer GM, Gross BH, Aisen AM, Quint LE, Francis IR, Orringer MB. Imaging of the pulmonary hilum: a prospective comparative study in patients with lung cancer. AJR Am J Roentgenol 1985;145:245–248. Crossref, MedlineGoogle Scholar
  • 15 White PG, Adams H, Crane MD, Butchart EG. Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumors? Thorax 1994;49:951–957. Crossref, MedlineGoogle Scholar
  • 16 Primack SL, Lee KS, Logan PM, Miller RR, Müller NL. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology 1994;193:795–800. LinkGoogle Scholar
  • 17 Dillemans B, Deneffe G, Verschakelen J, Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer: a study of 569 patients. Eur J Cardiothorac Surg 1994;8:37–42. Crossref, MedlineGoogle Scholar
  • 18 Yokoi K, Okuyama A, Mori K, et al. Mediastinal lymph node metastasis from lung cancer: evaluation with 201TI-SPECT: comparison with CT. Radiology 1994;192:813–817. LinkGoogle Scholar
  • 19 Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MRI imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705–713. LinkGoogle Scholar
  • 20 Seely JM, Mayo JR, Miller RR, Müller NL. T1 lung cancer: prevalence of mediastinal lymph node metastases and diagnostic accuracy of CT. Radiology 1993;186:129–132. LinkGoogle Scholar
  • 21 Verhagen AF, Bootsma GP, Tjan-Heijnen VC, et al. FDG-PET in staging lung cancer: how does it change the algorithm? Lung Cancer 2004;44:175–181. Google Scholar
  • 22 Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT. Radiology 1999;213:530–536. LinkGoogle Scholar
  • 23 Marom EM, McAdams HP, Erasmus JJ, et al. Staging non-small cell lung cancer with whole-body PET. Radiology 1999;212:803–809. LinkGoogle Scholar
  • 24 Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994;191:371–377. LinkGoogle Scholar
  • 25 Steinert HC, Hauser M, Allenmann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202:441–446. LinkGoogle Scholar
  • 26 Weng E, Tran L, Rege S, et al. Accuracy and clinical impact of mediastinal lymph node staging with FDG-PET imaging in potentially resectable lung cancer. Am J Clin Oncol 2000;23:47–52. Crossref, MedlineGoogle Scholar
  • 27 Paquet N, Albert A, Foidart J, Hustinx R. Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues. J Nucl Med 2004;45:784–788. MedlineGoogle Scholar
  • 28 Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500–2507. Crossref, MedlineGoogle Scholar
  • 29 Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003;229:526–533. LinkGoogle Scholar
  • 30 Deslauriers J, Gregoire J. Clinical and surgical staging of non-small cell lung cancer. Chest 2000; 117(4 suppl 1):96S–103S. Crossref, MedlineGoogle Scholar
  • 31 Staples CA, Müller NL, Miller RR, Evans KG, Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy. Radiology 1988;167:367–372. LinkGoogle Scholar
  • 32 Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000;343:254–261. Crossref, MedlineGoogle Scholar

Article History

Published in print: Sept 2005